Understanding tryptophan metabolism in healthy young adults
Official title: Tryptophan Metabolism in Healthy Young Adults in Response to Graded Tryptophan Intakes: a Pilot Study
Run by The Hospital for Sick Children · NCT06551545 · Data updated 2026-05-14
This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.
This study is testing how healthy young adults process tryptophan, an important amino acid, to see how it affects their health, especially during immune responses.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 45 Years |
| Sex | Men only |
| Enrollment | 6 (estimated) |
| Sponsor | The Hospital for Sick Children Academic / other |
| Locations | 1 site (Toronto, Ontario) |
| Trial ID | NCT06551545 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthy adults aged 18 to 45 who meet specific health criteria.
✕Probably not a fit
Patients with chronic diseases or acute illnesses affecting protein metabolism, or those on certain medications, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates how tryptophan, an essential amino acid, is metabolized in healthy young adults. It aims to develop a method to measure the breakdown products of tryptophan, particularly during immune activation, which may have implications for preterm infants receiving total parenteral nutrition. By examining the competition between the kynurenine and serotonin pathways, the study seeks to clarify how tryptophan metabolism can affect neurological health. Participants will be monitored for their metabolic responses to controlled tryptophan intake.
Why it matters
Potential benefit: If successful, this study could lead to improved nutritional strategies for preterm infants, reducing the risk of neurotoxic effects from tryptophan breakdown.
How similar studies have gone: While the specific approach of this study is novel, related research on tryptophan metabolism has shown potential for understanding its implications in health.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Consent provided 2. Aged 18 to 45 years old (inclusive) 3. In good general health as evidenced by medical history, physical health and biochemistry 4. Fasting blood glucose, hemoglobin A1c (HbA1c), urea, creatinine and CRP levels within normal ranges for age. Exclusion Criteria: 1. Presence of chronic disease and/or acute illness known to affect protein/amino acid metabolism (e.g. HIV, diabetes, cancer, liver or kidney disease, neurological conditions including depression and anxiety, hypo- / hyperthyroidism, inflammatory conditions,, anemia, acute cold or flu) 2. Taking medications known to affect protein/AA metabolism (e.g. steroids, anti-inflammatory medications, acetaminophen, selective serotonin reuptake inhibitors (SSRI)) 3. Inability to tolerate the diet (i.e. allergy) 4. Significant weight loss during the past month or consumption of weight reducing diets. 5. Significant caffeine consumption (\>2 cups per day) 6. Significant consumption of alcohol (\>1 drink per day i.e. 1 beer or ½ glass of wine). 7. Unwilling to have blood drawn from a venous access or using a ventilated hood indirect calorimeter for the purposes of the study.
Where it's running
-
The Hospital for Sick Children
Toronto, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Glenda Courtney-Martin, PhD, RD — The Hospital for Sick Children
- Study coordinator: Nisha Pai, MSc, RD
- Email: nisha.pai@sickkids.ca
- Phone: 289-208-4990
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Do Quercefit® or Ubiqsome™ help with aging and metabolic health in adults 50–75?
This study tests whether Quercefit® or Ubiqsome™ can improve aging markers, blood sugar, and heart health in sedentary adults aged 50–75 compared with a placebo.
-
NVTIA Ergothioneine for Healthy Aging and Skin Health
This study tests whether taking NVTIA Ergothioneine daily for 12 weeks helps healthy adults age more gracefully and keeps skin looking and feeling better compared with a placebo.
-
Miricell supplementation and markers of healthy aging
This trial tests whether taking Miricell once daily for 12 weeks improves cellular health and brain/metabolic indicators in adults aged 40–70 compared with a placebo.
-
Does daily lean beef support brain health in older adults
In healthy adults aged 65 and up, this study tests whether eating lean beef every day for two weeks can influence brain health markers compared with a non-beef, protein-matched option.
-
Adaptive computerized training to boost thinking in healthy seniors and those with mild cognitive impairment
This study tests whether a computer-based training program can improve executive thinking in older adults, including those with mild cognitive impairment, and see if it also helps memory and well-being.
-
SHARP: Personalized Health and Behavior Plan to Lower Biological Age in Older Adults
A 12-month randomized trial tests whether a personalized health and behavior program can lower biological age and improve function in healthy adults over 50.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.